Esperion Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ESPR) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -35.33 M12.36 M22.63 M31.42 M4.29 M 70.69 M Cash from investing activities 167 K0000 0 Cash from financing activities -9.1 M35 M7.5 M-2.85 M1.37 M 41.02 M Free cash flow -35.49 M12.36 M22.63 M31.42 M4.29 M 70.69 M

Esperion Therapeutics Inc

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

新闻

Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?

Esperion stock delivers 77% gain since InvestingPro’s April 2024 Fair Value call

Esperion settles patent dispute with Alkem over cholesterol drugs

Esperion Therapeutics general counsel sells $4.9k in stock

H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Absci (NASDAQ:ABSI), Buckle (NYSE:BKE)

Esperion Therapeutics, Inc. (ESPR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Intel and Visa among market cap stock movers on Tuesday

Esperion stock delivers 77% gain since InvestingPro’s April 2024 Fair Value call

Esperion stock hits fair value target with 77% gain since April 2024

AMD, Merck among market cap stock movers on Tuesday

AMD, Nvidia among market cap stock movers on Tuesday

Abercrombie & Fitch, Titan Machinery, Zoom Communications, Woodward And Other Big Stocks Moving Higher On Tuesday - Abercrombie & Fitch (NYSE:ANF), Amentum Holdings (NYSE:AMTM)